Divi's Lab.

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,056.65",
    "chg": 216.15,
    "chgp": "2.76%",
    "dir": 1,
    "prev_price": "7,840.50",
    "mcapval": "213,019.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "Jul 31, 03:30 PM",
    "curr_time": "12:21 PM",
    "last_traded_at": "Jul 31, 03:30 PM IST",
    "bse_nse_vol": "8.45 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Gains 11.18%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-1118-5-key-factors-driving-the-weeks-rally-4131922",
        "imagepath": "",
        "date": "2026-08-01 17:05:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> New 52-week high at Rs.7,451.55 and surge in call and put option activity ahead of expiry</p>\n                    <p><strong>28 Jul:</strong> All-time high reached at Rs.7,489, continuing upward momentum</p>\n                    <p><strong>29 Jul:</strong> Multiple new highs including intraday peak of Rs.7,674 and sharp open interest surge</p>\n                    <p><strong>30 Jul:</strong> New 52-week high at Rs.7,886.55 amid sectoral strength</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.8,056.65 with a 3.06% intraday gain and new all-time high</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div cla..."
      },
      {
        "title": "Divi's Laboratories Q1 FY27: Stellar Quarter Drives Stock to New Highs",
        "link": "https://www.marketsmojo.com/news/result-analysis/divis-laboratories-q1-fy27-stellar-quarter-drives-stock-to-new-highs-4132032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DivisLaboratori_quaterlyResult_4132032.png",
        "date": "2026-08-01 16:47:37",
        "description": "Divi's Laboratories Ltd., one of India's leading active pharmaceutical ingredient (API) manufacturers, delivered an exceptional first quarter for FY27, posting a net profit of ₹902.00 crores—a remarkable 65.50% surge year-on-year and 20.11% quarter-on-quarter growth. The stellar performance propelled the stock to ₹8,056.65 on July 31, 2026, gaining 2.76% on the day and touching a fresh 52-week high of ₹8,087.00, reflecting robust investor confidence in the company's operational momentum."
      },
      {
        "title": "Divis Laboratories Ltd Surges 3.06% to Day's High of Rs 8086.55 — Outperforms Sector by 2.05 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-high-with-strong-306-surge-4130528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_priceRelatedfactors_4130528.png",
        "date": "2026-07-31 15:31:43",
        "description": "The Sensex edged up 0.13% on 31 Jul 2026, while Divis Laboratories Ltd surged 3.06%, touching a new 52-week and all-time high of Rs 8086.55. This 2.05 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a stock-specific strength rather than a broad market rally."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Divis Laboratories Ltd to 52-Week High of Rs 8086.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-new-52-week-high-at-rs-808655-4129804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_priceRelatedfactors_4129804.png",
        "date": "2026-07-31 09:45:08",
        "description": "With a decisive surge to Rs 8,086.55 on 31 Jul 2026, Divis Laboratories Ltd has reached a new 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Divis Laboratories Ltd to 52-Week High of Rs 7,886.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-new-52-week-high-at-rs-788655-4128210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_priceRelatedfactors_4128210.png",
        "date": "2026-07-30 09:43:07",
        "description": "With a decisive break above its previous peaks, Divis Laboratories Ltd has surged to a new 52-week high of Rs 7,886.55 on 30 Jul 2026, marking a significant milestone in its price momentum. This advance comes amid a sustained four-day rally that has delivered nearly 8% returns, underscoring the stock’s robust technical positioning despite a broadly flat Sensex."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-strong-market-momentum-4126176",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4126176.png",
        "date": "2026-07-29 15:00:22",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and shifting investor sentiment. The stock hit a new 52-week high of Rs 7,787.5 on 29 Jul 2026, outperforming its sector peers and signalling robust bullish positioning among traders."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-strong-market-momentum-4126125",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4126125.png",
        "date": "2026-07-29 14:00:21",
        "description": "Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, hitting a fresh 52-week high and attracting increased investor participation, reflecting growing confidence in its near-term prospects."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-strong-market-momentum-4126052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4126052.png",
        "date": "2026-07-29 13:00:18",
        "description": "Divis Laboratories Ltd (DIVISLAB) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical giant’s stock hit a new 52-week high of Rs 7,744 on 29 Jul 2026, supported by robust volume and sustained buying interest, reflecting growing bullish sentiment among traders and investors alike."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-strong-market-momentum-4126004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DivisLaboratori_oi_spurts_by_underlying_4126004.png",
        "date": "2026-07-29 12:00:19",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved investor sentiment, underscores a bullish outlook supported by robust fundamentals and technical strength."
      }
    ],
    "total": 704,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "31-Jul-2026",
      "details": "Intimation of retirement of Senior Management Personnel as detailed in the enclosed letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "24-Jul-2026",
      "details": "Schedule of earnings conference call for Q1 FY27",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026.",
      "datetime": "20-Jul-2026",
      "details": "Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 inter alia to consider and approve the unaudited financial results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Gains 11.18%: 5 Key Factors Driving the Week’s Rally

2026-08-01 17:05:55

Key Events This Week

27 Jul: New 52-week high at Rs.7,451.55 and surge in call and put option activity ahead of expiry

28 Jul: All-time high reached at Rs.7,489, continuing upward momentum

29 Jul: Multiple new highs including intraday peak of Rs.7,674 and sharp open interest surge

30 Jul: New 52-week high at Rs.7,886.55 amid sectoral strength

31 Jul: Week closes at Rs.8,056.65 with a 3.06% intraday gain and new all-time high

Read full news article

Divi's Laboratories Q1 FY27: Stellar Quarter Drives Stock to New Highs

2026-08-01 16:47:37

Divi's Laboratories Ltd., one of India's leading active pharmaceutical ingredient (API) manufacturers, delivered an exceptional first quarter for FY27, posting a net profit of ₹902.00 crores—a remarkable 65.50% surge year-on-year and 20.11% quarter-on-quarter growth. The stellar performance propelled the stock to ₹8,056.65 on July 31, 2026, gaining 2.76% on the day and touching a fresh 52-week high of ₹8,087.00, reflecting robust investor confidence in the company's operational momentum.

Read full news article

Divis Laboratories Ltd Surges 3.06% to Day's High of Rs 8086.55 — Outperforms Sector by 2.05 Percentage Points

2026-07-31 15:31:43

The Sensex edged up 0.13% on 31 Jul 2026, while Divis Laboratories Ltd surged 3.06%, touching a new 52-week and all-time high of Rs 8086.55. This 2.05 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a stock-specific strength rather than a broad market rally.

Read full news article

Broad-Based Technical Strength Lifts Divis Laboratories Ltd to 52-Week High of Rs 8086.55

2026-07-31 09:45:08

With a decisive surge to Rs 8,086.55 on 31 Jul 2026, Divis Laboratories Ltd has reached a new 52-week and all-time high, propelled by a confluence of bullish technical indicators and sustained price momentum.

Read full news article

Broad-Based Technical Strength Lifts Divis Laboratories Ltd to 52-Week High of Rs 7,886.55

2026-07-30 09:43:07

With a decisive break above its previous peaks, Divis Laboratories Ltd has surged to a new 52-week high of Rs 7,886.55 on 30 Jul 2026, marking a significant milestone in its price momentum. This advance comes amid a sustained four-day rally that has delivered nearly 8% returns, underscoring the stock’s robust technical positioning despite a broadly flat Sensex.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum

2026-07-29 15:00:22

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant surge in open interest (OI) in its derivatives segment, reflecting heightened market activity and shifting investor sentiment. The stock hit a new 52-week high of Rs 7,787.5 on 29 Jul 2026, outperforming its sector peers and signalling robust bullish positioning among traders.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum

2026-07-29 14:00:21

Divis Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, hitting a fresh 52-week high and attracting increased investor participation, reflecting growing confidence in its near-term prospects.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum

2026-07-29 13:00:18

Divis Laboratories Ltd (DIVISLAB) has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical giant’s stock hit a new 52-week high of Rs 7,744 on 29 Jul 2026, supported by robust volume and sustained buying interest, reflecting growing bullish sentiment among traders and investors alike.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Strong Market Momentum

2026-07-29 12:00:19

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved investor sentiment, underscores a bullish outlook supported by robust fundamentals and technical strength.

Read full news article

View All News